The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A Phase I and Pharmacology Study of the Novel Antimicrotubule Depolymerising Agent T138067
 
Vincent M. Chung
Consulting or Advisory Role - Celgene; Perthera
Speakers' Bureau - Celgene
 
Ferdynand Kos
No Relationships to Disclose
 
Nicola Hardwick
No Relationships to Disclose
 
Yuan Yuan
Consulting or Advisory Role - Novartis; Pfizer
Research Funding - Eisai; Merck; Pfizer
 
Joseph Chao
Consulting or Advisory Role - Bayer; Boston Biomedical; Five Prime Therapeutics; Lilly
Research Funding - Merck (Inst); Novonco Therapeutics (Inst)
 
Mengsha Li
No Relationships to Disclose
 
Kathryn Zurcher
No Relationships to Disclose
 
Paul Henry Frankel
Other Relationship - FlexSim; FlexSim
 
Daneng Li
No Relationships to Disclose
 
James Ross Waisman
No Relationships to Disclose
 
Don J. Diamond
Stock and Other Ownership Interests - Helocyte
Consulting or Advisory Role - Helocyte
Patents, Royalties, Other Intellectual Property - Beckman Coulter; Cell Medica; IBA Lifesciences; Immtech; MBL International; Qiagen; Stage Cell Therapeutics